Funding Details
- Awarder
- YCombinator
- Date Award
- February 12, 2025
- Vertical
- B2B,Engineering, Product and Design
- Funding URL
- View Funding Page
- Valuation
-
$0
Company Info
- Founding Year
- 2025
- Company Description
- 90% of drug candidates fail despite billions in pharmaceutical R&D.
Delineate extracts and analyzes data from biopharma research papers and patents at scale, including data trapped in figures and plots.
Led by Emily (MIT PhD, former Pfizer/AstraZeneca computational researcher) and Jawad (ex-Lockheed Skunkworks AI lead), Delineate has developed custom LLM and computer vision models paired with rigorous QC processes to deliver extremely high quality datasets in a fraction of the time.
By processing 15x more studies than industry standard and reducing months of research into weeks, we're transforming how pharmaceutical companies make evidence based development decisions.
Delineate has generated $160K in revenue through data contracts with Sanofi and Roche, conducting some of the largest aggregated research studies to date.
- Market
- B2B
- Location
-
Boston,
MA,
USA; Remote
- Coinvestors
- YCombinator
Links